Cargando…
Computational Analysis of Pathogenetic Pathways in Alzheimer’s Disease and Prediction of Potential Therapeutic Drugs
Background. Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disease which affects more than 50 million patients and represents 60–80% of all cases of dementia. Mutations in the APP gene, mostly affecting the γ-secretase site of cleavage and presenilin mutations, have been ide...
Autores principales: | Petralia, Maria Cristina, Mangano, Katia, Quattropani, Maria Catena, Lenzo, Vittorio, Nicoletti, Ferdinando, Fagone, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313152/ https://www.ncbi.nlm.nih.gov/pubmed/35884634 http://dx.doi.org/10.3390/brainsci12070827 |
Ejemplares similares
-
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer’s Disease Patients and In Silico Prediction of Potential Repurposable Drugs
por: Fagone, Paolo, et al.
Publicado: (2022) -
The Role of Macrophage Migration Inhibitory Factor in Alzheimer′s Disease: Conventionally Pathogenetic or Unconventionally Protective?
por: Petralia, Maria Cristina, et al.
Publicado: (2020) -
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018) -
Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus
por: Petralia, Maria Cristina, et al.
Publicado: (2021) -
Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms
por: Basile, Maria Sofia, et al.
Publicado: (2021)